Daggubati, V., Hochstelter, J., Bommireddy, A., Choudhury, A., Krup, A. L., Choski, P., . . . Raleigh, D. (2021). EMBR-16. SMOOTHENED-ACTIVATING LIPIDS DRIVE RESISTANCE TO CDK4/6 INHIBITION IN HEDGEHOG-ASSOCIATED MEDULLOBLASTOMA. Neuro Oncol.
Citación estilo ChicagoDaggubati, Vikas, et al. "EMBR-16. SMOOTHENED-ACTIVATING LIPIDS DRIVE RESISTANCE TO CDK4/6 INHIBITION IN HEDGEHOG-ASSOCIATED MEDULLOBLASTOMA." Neuro Oncol 2021.
Cita MLADaggubati, Vikas, et al. "EMBR-16. SMOOTHENED-ACTIVATING LIPIDS DRIVE RESISTANCE TO CDK4/6 INHIBITION IN HEDGEHOG-ASSOCIATED MEDULLOBLASTOMA." Neuro Oncol 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.